Home › Forums › Main Forum › Media & News › Drug companies paying hundreds of NHS officials
- This topic has 6 replies, 4 voices, and was last updated 8 years, 10 months ago by Gaj.
-
AuthorPosts
-
17 February 2016 at 11:44 am #12096
Weeeeelllll, who woudda thought it
hundreds of NHS officials responsible for assessing which drugs should be prescribed to patients continue to be on the payroll of large pharmaceutical companies, an investigation has found.
More than 140 members of health service staff are receiving generous consultancy fees from the same drugs companies whose products they are responsible for considering on behalf of the NHS.
Ministers announced an urgent investigation last night and promised to take action against any officials found to have acted improperly after revelations made by The Daily Telegraph. MPs criticised the “murky” practice for the potential conflict of interest.http://www.thetimes.co.uk/tto/health/news/article4692556.ece
and it’s not just ‘officials’ either but yes, clinicians, some whose education has been funded by drug companies, charities and ‘health’ forums
GT1a Dec14 F2/8.7 VL 900000-2.5M
Jan16 Hepcivir-L MonkMed/Redemption
Baseline: VL 913575 Alt 76 Platelets low
Wk2 VL1157 Alt 23
DET Wk 8 VL 32 Alt19 ‘In the slow lane’
June16 Fibro 5.7 F0/1 LIF 1.5
Wk 11 VL<12 Alt 13 Det/Unq
Extending tx 12 wks Mylan Sofo/Dac MonkMed
Wk 14 VL <12 Det/Unq
Wk 16 VL UNDETECTED
Wk 22 + 4 Wks Sunprevir FixHepC
Wk 24 UNDETECTED Alt 13
Wk 12 post tx SVR12 Wk 26 SVR24
Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC17 February 2016 at 1:05 pm #12100Many of the doctors who participated in Gilead’s Sofosbuvir clinical trials are either paid speakers for Gilead or are members of Gilead’s advisory board. What’s even worse, Dr John Mchutchison who did at least 20 of Gilead’s Sofosbuvir studies (see link below) is Senior Vice President, Liver Disease Therapeutics for Gilead and is in charge of “research and development efforts supporting the company’s programs in liver disease, including hepatitis C”.(see second link).
That is a HUGE conflict of interest and totally unethical. I can’t believe that he was allowed to do that.
17 February 2016 at 1:18 pm #12101Just what I needed to start my day feeling homicidal. But that won’t do anybody any good.
What will do good is to bring this shit into the light of day. Thank heavens it is happening!
dt17 February 2016 at 1:23 pm #12102Yes, my previous consultant’s education was funded by all the big pharma. He who lied to me and offered no monitoring which ever route I took and quite clearly wanted me to wait using emotional blackmail among other tricks along with two wopping lies, one on paper.
Drug companies do need the advise of medical experts, it’s ho far that ‘advise’ goes … and if it gets into ‘murky waters’.
The good news is, they’ve been rumbled, let’s hope UK ‘civil socity’ actually DO something about it.
To think that these peoples actions cause restrictions to patients accessing these meds while raking in the dosh is uttery contemptable the fact that they work for the NHS makes it doubly so.
GT1a Dec14 F2/8.7 VL 900000-2.5M
Jan16 Hepcivir-L MonkMed/Redemption
Baseline: VL 913575 Alt 76 Platelets low
Wk2 VL1157 Alt 23
DET Wk 8 VL 32 Alt19 ‘In the slow lane’
June16 Fibro 5.7 F0/1 LIF 1.5
Wk 11 VL<12 Alt 13 Det/Unq
Extending tx 12 wks Mylan Sofo/Dac MonkMed
Wk 14 VL <12 Det/Unq
Wk 16 VL UNDETECTED
Wk 22 + 4 Wks Sunprevir FixHepC
Wk 24 UNDETECTED Alt 13
Wk 12 post tx SVR12 Wk 26 SVR24
Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC17 February 2016 at 1:25 pm #12103Yes, the Times, The Telegraph and the Daily Snail so far, but some good MPs are asking questions.
Plus of course, good ol’ Twitter. Please help spread the word UK people, don’t let them slither away with it ….
GT1a Dec14 F2/8.7 VL 900000-2.5M
Jan16 Hepcivir-L MonkMed/Redemption
Baseline: VL 913575 Alt 76 Platelets low
Wk2 VL1157 Alt 23
DET Wk 8 VL 32 Alt19 ‘In the slow lane’
June16 Fibro 5.7 F0/1 LIF 1.5
Wk 11 VL<12 Alt 13 Det/Unq
Extending tx 12 wks Mylan Sofo/Dac MonkMed
Wk 14 VL <12 Det/Unq
Wk 16 VL UNDETECTED
Wk 22 + 4 Wks Sunprevir FixHepC
Wk 24 UNDETECTED Alt 13
Wk 12 post tx SVR12 Wk 26 SVR24
Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC19 February 2016 at 12:51 am #12199The big difference is in whether the funding helps patients or helps yourself.
I’m not ashamed to admit that I used to be a speaker for two drug companies. Back then, the medical group I was working for allowed patients a dose of Ribavirin of 800mg daily for all genotypes, while the rest of the world was using 1000mg-1200mg. My being a speaker gave the patients under my care the extra amount they needed from free samples When they got anemic it gave them Procrit which until then we’d been unable to get for them.
I got paid $500 for doing a 45 min lecture. I did lectures for support groups and donated the money to them. You should have seen, I was a very popular speaker
19 February 2016 at 4:05 am #12206Thank you Price,
I’ve noted a couple of times previously that the total segregation of pharma and medico is unlikely to be beneficial to the advancement of medicine or the welfare of patients in the real world. I would also suggest that it is not just about whether it helps the patient vs self but also any undue influence on decisions that can have long term consequences. It really comes down to how ‘cozy’ these arrangements become. This is exactly why we need, and have, ‘Conflict of Interest’ statements at the end of most academic papers, it doesn’t necessarily mean there a conflict but it allows everyone to see that there is a potential for it to occur. And allows others to ask questions to resolve any concerns.
In my view, experts accepting monies to attend or speak at conferences, participate in study, conduct clinical trials, etc. that can’t/won’t be funded by governments, hospitals or the individual are within the bounds of acceptable behaviour providing they are declared, on subject and limited to reasonable costs. i.e. I don’t expect an Australian specialist flying to the AASLD conferences to stay in a caravan while he is there, but nor do I expect that he would be taken to Broadway shows unless he pays for the ticket himself.
However, being a board member for a commercial corporation while having input to decisions by government/hospitals/etc. is not something that should be allowed. As such I also suspect the NHS officials commented on earlier should be disqualified from any decision processes that have anything at all to do with those from who they have received funding.
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
-
AuthorPosts
- You must be logged in to reply to this topic.